Synthesized Oligonucleotides Market is Expected to Reach $1,712.1 Million by 2019 - New Research Report by MarketsandMarkets

Share Article

This report studies the oligonucleotide synthesis market by products and services, applications, end users, and geography. http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

MarketsandMarkets

MarketsandMarkets

Glen Research (U.S.), Gene Link, Inc. (U.S.), GenScript USA Inc. (U.S.), GeneDesign, Inc. (Japan), Integrated DNA Technologies, Inc. (IDT) (U.S.), Link Technologies, Ltd. (U.K.)

The global oligonucleotide synthesis market is expected to reach $1,712.1 million by 2019 from $1,070.7 million in 2014, growing at a CAGR of 9.8% from 2014 to 2019.

For Full Report at http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

Prominent players in the oligonucleotide synthesis market are Agilent Technologies, Inc. (U.S.), BioAutomation Corporation (U.S.), BioSearch Technologies, Inc. (U.S.), Eurofins Genomics (Germany), Eurogentec (Belgium), GE Healthcare (U.K.), Glen Research (U.S.), Gene Link, Inc. (U.S.), GenScript USA, Inc. (U.S.), GeneDesign, Inc. (Japan), Integrated DNA Technologies, Inc. (IDT) (U.S.), Link Technologies, Ltd. (U.K.), Nitto Denko Avecia, Inc. (U.S.), Sigma-Aldrich Co. LLC. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and TriLink BioTechnologies, Inc. (U.S.).

For Report Inquiry at http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=200829350

The oligonucleotide synthesis market is a moderately consolidated market, divided into various segments. Each segment possesses different market players and leaders. For instance, the equipment market was led by BioAutomation Corporation (U.S.) in 2013. The company’s MerMade synthesizers are widely used for oligonucleotide synthesis. BioAutomation offers a full line of DNA/RNA oligonucleotide synthesizers as well as custom models to scientists and researchers in the field of biotechnology so as to cope with their changing requirements.

After acquiring Life Technologies, Thermo Fisher Scientific strengthened its oligonucleotide product portfolio. Thermo Fisher Scientific, Inc. (U.S.) led the oligonucleotide synthesis reagents market in 2013. The company has a wide product portfolio that includes primers, probes, reagents, phosphoramidites, and custom oligos. The company leverages its strong brand name and market presence in the market to gain a competitive edge. The company is innovation-centric and invests heavily in R&D. Moreover, it possesses a strong sales force, which helps it to sell its products efficiently. The company believes in growth both organic and inorganic for enhancing its market position.

Get PDF Manual at http://www.marketsandmarkets.com/pdfdownload.asp?id=200829350

The key strategies followed by most companies in the oligonucleotide synthesis market are new product launches, agreements, collaborations, and partnerships, acquisitions, and expansions. Among all growth strategies being adopted by players in this field, agreements, collaborations, and partnerships, and acquisitions accounted for the largest share of the overall growth strategies mapped from 2011 to 2014. Some leading players adopting these strategies are BioAutomation Corporation (U.S.), Eurofins Genomics (Germany) and GE Life Sciences (U.S.). Expansions accounted for the second largest share of the overall growth strategies adopted by players in the market.

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
e-mail: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog at http://mnmblog.org/market-research/healthcare/biotechnology

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Mr. Rohan
@mmarketmonitor
Follow >
Micro Market Monitor
Like >
Follow us on